Drug profile · INN
l-glutamine
ENDARI
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
l-glutamine (ENDARI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →Frequently asked questions
What is l-glutamine?
l-glutamine (ENDARI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for l-glutamine?
ENDARI is a marketed brand name for l-glutamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of l-glutamine?
l-glutamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.